Rationale Preclinical studies suggest that stress potentiates cue-induced cocaine seeking and that this effect is more pronounced in females. These findings have not been characterized in clinical populations. Objectives The objectives of this study were to examine the impact a pharmacological stressor, alpha-2 adrenergic receptor antagonist yohimbine, on the subjective, endocrine, and physiologic responses to drug-paired cues cocaine-dependent men and women. Methods In a double-blind placebo-controlled cross-over study, cocaine-dependent men (n=32), cocaine-dependent women (n=30), control men (n=32), and control women (n=25) received either yohimbine or placebo prior to two cocaine cue exposure sessions. Results Yohimbine increased ratings of anxiety both before (p<0.001) and after (p=0.035) cues, and the post-cue increase in anxiety was more pronounced in women (p=0.001). Yohimbine also significantly increased craving, compared with placebo (p<0.05), following the cue presentation, and this effect was greater in women than men (gender by treatment interaction; p=0.006). Yohimbine also increased salivary cortisol (p < 0.001) and dehydroepiandrosterone (p = 0.003) levels, regardless of diagnostic group. Women had a significantly greater heart rate response following yohimbine as compared with men (p<0.001). Conclusions Stress may increase the salience of cocaine cues for cocaine-dependent women as compared with men. This suggests gender differences in vulnerability to craving and relapse under stressful conditions.
Introduction
Both stress-and drug-related environmental cues contribute to the high rates of relapse among cocaine-dependent individuals (Alleweireldt et al. 2001; Erb et al. 1996; Preston and Epstein 2011; Sinha et al. 1999 Sinha et al. , 2000 . Although both have been studied separately, few studies have investigated their interaction, especially in cocaine-dependent individuals. Moreover, although both stress and cue reactivity differ in cocainedependent men and women (Back et al. 2005; Fox et al. 2006; McKay et al. 1996; Waldrop et al. 2009 ), few studies have examined the relationships between drug-related cues and stress in men versus women.
Preclinical studies demonstrate that stress-and drug-paired cues interactively influence drug-seeking behavior in rodents trained to self-administer drugs. For example, pharmacological provocation of the noradrenergic stress system with the alpha-2 adrenergic receptor antagonist yohimbine potentiates cue-induced reinstatement of both cocaine-and heroinseeking behaviors (Banna et al. 2010; Feltenstein and See 2006) , and footshock stress potentiates cue-induced reinstatement of both cocaine-and ethanol-seeking behaviors (Buffalari and See 2009; Liu and Weiss 2002) . These preclinical data suggest that the combined effects of stress and drug cues may increase the vulnerability of substance-dependent individuals to relapse.
There is some evidence that there are sex differences in the role in the relapse (McKay et al. 1996) . Compared with cocaine-dependent men, cocaine-dependent women report greater stress and nervousness in response to laboratory stress tasks (Back et al. 2005; Waldrop et al. 2009 ). In rodents, female animals exhibit greater drug-seeking behavior in response to pharmacological stressors than male rodents (Anker and Carroll 2010; Buffalari et al. 2012) . Of note, yohimbine potentiates cue-induced reinstatement of cocaine-seeking behavior to a greater extent in female, compared with male rodents (Feltenstein et al. 2011 ). Sex differences in the interaction between stress-and drug-paired cues have not previously been investigated in clinical populations of cocainedependent men and women.
The primary focus of the present study was to examine the effects of the pharmacological stressor, yohimbine, on subjective, endocrine, and physiologic responses to drug-related cues in a clinical population of cocaine-dependent men and women. We hypothesized that yohimbine would increase reactivity to cues (compared with placebo), and that this effect would be greater in women than men.
Methods

Study participants
Study participants were recruited primarily via media advertisements over a 48-month period. Written informed consent was obtained before study assessments were administered. All procedures were conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki and received Institutional Review Board (IRB) approval. Inclusion criterion for the cocaine-dependent groups included (1) Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria for cocaine dependence in the 90 days prior to the study. Exclusion criterion for the cocaine-dependent groups included (1) DSM-IV criteria for substance dependence except caffeine, nicotine, alcohol or marijuana within the past 60 days. Exclusion criteria for the control groups included (1) DSM-IV criteria for current or lifetime dependence on alcohol or any drugs of abuse except nicotine and caffeine and (2) DSM-IV criteria for current abuse of alcohol or any illicit drugs. General exclusion criteria included (1) pregnancy, nursing, or ineffective means of birth control; (2) premenstrual dysphoric disorder; (3) history of or current significant hematological, endocrine, cardiovascular, pulmonary, renal, gastrointestinal, or neurological diseases; (4) history of or current psychotic, panic, eating, or bipolar affective disorders; (5) current major depressive and PTSD; (6) history of or current medical conditions that might affect hypothalamic-pituitaryadrenal (HPA) axis activity; (7) synthetic glucocorticoid or exogenous steroid therapy within 1 month of testing; (8) psychotropic medications with the exception of selective serotonin reuptake inhibitors, opiates, or opiate antagonists, benzodiazepines, antipsychotics, b-blockers, and other medications that might interfere with HPA axis activity or physiologic measurements; (9) acute illness or fever; (10) body mass index of >35; and (11) unwillingness or inability to maintain abstinence from alcohol and other drugs of abuse (except nicotine) for 3 days prior to the cue-reactivity sessions.
Assessment
Subjects meeting preliminary screen criteria were evaluated for study eligibility with the Mini-International Neuropsychiatric Interview (MINI), which permits accurate diagnosis of current psychiatric disorders using DSM-IV criteria (Sheehan et al. 1998) . The substance use module of the Structured Clinical Interview for DSM-IV (SCID-IV), was used for current and lifetime substance use disorder diagnosis (First et al. 1994) . Substance use in the 90 days prior to study enrollment and throughout the study period was assessed using the Time-Line Follow-Back (Sobell and Sobell 1992) . If a participant met criteria for alcohol dependence, the Severity of Alcohol Dependence Questionnaire was administered (Stockwell et al. 1983 ). Participants scoring 10 or higher were evaluated by a clinician prior to enrollment. Menstrual history data was collected from female participants. A medical history and physical examination, including electrocardiogram were completed to assess for medical exclusions. Following baseline assessments, participants meeting inclusion criteria and no exclusion criteria were scheduled to complete the laboratory procedures.
Laboratory procedures
Subjects participated in two cue exposure sessions on consecutive days. On the first day of testing, participants arrived at the Clinical and Translational Research Center (CTRC) of the Medical University of South Carolina at 10:00 a.m. Upon arrival, urine pregnancy tests were administered to female participants. Smokers were provided with a nicotine patch. Subjects were required to abstain from alcohol or other substance use (except nicotine and caffeine) for a minimum of 3 days prior to testing. Abstinence was assessed using self-reports, urine drug screens (Roche Diagnostics, Indianapolis, IN), and breathalyzer tests (AlcoSensor III, Intoximeters, Inc., St. Louis, MO), which were administered prior to each cue-reactivity session. If the pregnancy and drug tests were negative (with the exception of THC), study procedures continued.
The study was conducted using a double-blind placebocontrolled design. At 11:00 a.m., baseline salivary cortisol and dehydroepiandrosterone (DHEA) samples were collected. At 12:00 p.m., subjects received either yohimbine hydrochloride (Spectrum Laboratories, Inc., New Brunswick, NJ) 21.6 mg or a matching placebo capsule. Treatment order was counterbalanced across the two cue-reactivity sessions. Participants were randomized to treatment by sex and by diagnostic group, such that half of the participants in each group received yohimbine prior to the first cue reactivity session and half of the participants received placebo. Identical yohimbine and placebo capsules were compounded by the MUSC Investigational Drug Service, who managed the study randomization procedures and recorded treatment assignment. The dose and timing of administration were selected based on previous studies (O 'Carroll et al. 1999; Swann et al. 2005) . At 12:15 p.m. the participants were provided with a standard lunch and were seated in the CTRC testing room where they were allowed to read until the testing procedures began. At 1:30 p.m., a blood pressure cuff was placed on the subject's arm. Subjective, endocrine (DHEA and cortisol) and heart rate data were collected, one at 1:40 p.m. and the second at 1:55 p.m. A modified version of the Within-Session Rating Scale was used to assess subjective responses (Childress et al. 1986 ). This 100-mm visual analog scale is anchored with the adjectival modifiers ("not at all, mildly, moderately, and extremely"). There are four items assessing domains of craving (want/need/ craving/ability to resist). Other items include anxiety, distress, and mood. At 2:00, the subject participated in a scripted imagery exercise regarding cocaine use. The scripted imagery session began with a brief relaxation exercise during which the subject was instructed to release any tension in the shoulders, back, and neck and to breathe deeply. The subject was then instructed to recall a time when they were using cocaine and to visualize the experience with as much sensory detail as possible including their physical response (increased heart rate and breathing) and the rush of excitement at the first hit of cocaine. Participants were then asked to view and handle cocaine-related paraphernalia. The cocaine cues consisted of a small bag of simulated crack cocaine, the subject's preferred style of crack pipe, a lighter, and money ($20 bill) for those who use crack cocaine. For powder or intravenous users, simulated cocaine and money were used. The cocaine cues were placed on the table directly in front of the subject. The subject was asked to inspect and handle the cues for a 2-min period. Following the completion of the "in vivo" exposure, the subjects viewed a 5-min film depicting cocaine use in a variety of settings. This combination of in vivo cues and cocaine use depiction has produced significant craving and physiologic activity in previous studies (Coffey et al. 2002; Saladin et al. 2003) . The cue-paradigm lasted for 10 min. Heart rate, subjective, and endocrine data were collected immediately after the cues and again 5-, 30-, and 60-min post-cue exposure. Afterwards, participants were escorted to a private room in the Medical University Hospital (MUH) where they spent the night. The following morning, participants were escorted back to the CTRC and repeated the study procedures described above with the alternate medication. Participants spent a second night in the MUH. At 11:00 a.m. the following morning, the subjects were debriefed, compensated for their participation, and discharged from the CTRC. Saliva samples were assayed by enzyme-linked immunosorbent assay using commercially available kits (Salimetrics, LLC, State College, PA) in the CTRC laboratory. The DHEA assay has a lower sensitivity limit of 5 pg/ml and a DHEA serum-saliva correlation of r=0.857). The cortisol kit has a lower sensitivity level of <0.003 μg/dl. The correlation between salivary and serum cortisol has been shown to be high (r=0.91).
Statistical analysis
This study was powered to determine if cocaine-dependent subjects would demonstrate greater cocaine craving after receiving yohimbine followed by exposure to cocaine-related cues as compared with cocaine-related cue exposure following administration of placebo. Sample size estimates were based on our own preliminary data from cocaine-dependent women. It was determined that 30 women and 30 men per group would be sufficient to achieve 80 % power with a type I error rate of 5 % to detect a 2-point (40 %) increase in cocaine craving.
A Wilcoxon rank sum test was used to evaluate continuous baseline demographic and clinical measures across groups, whereas the Pearson Chi-square test was used to assess the association among categorical and ordinal variables. To assess the association of treatment with yohimbine and response to cocaine cue, linear mixed effects models were developed that included all serial measurements made at each time point following administration of yohimbine or placebo (including the pre-cue/ post-treatment time points) (Patterson and Thompson 1971) . Models were fitted using SAS PROC MIXED using restricted maximum likelihood approach to account for unbalanced data, and model-based estimates were used to test the planned hypotheses. Pair-wise comparisons between treatment and groups were assessed at time points immediately prior to and following the presentation of the cue. Interactions were tested using all post-cue time points while controlling for pre-cue response levels. As the controls were not expected to crave cocaine, the analysis of the craving data was restricted to cocainedependent men and women. Cortisol and DHEA levels collected prior to the administration of yohimbine or placebo were collected and used as covariates in the analysis models. To achieve normality, the endocrine outcomes were log 10 transformed. All comparisons and statistical analysis were adjusted for baseline levels when available. Effects of drug administration order and cuereactivity session (day 1 vs. day 2) were tested in all models. No effects of the order of drug administration were determined to significantly affect the model estimates. Cue-reactivity session had trend-level significant effects on subjective responses, thus we controlled for cue-reactivity session the analyses.
All statistical analyses were performed using SAS, version 9.3 (SAS Institute, Cary, NC). Significance for all planned pair-wise comparisons was set at a two-sided alpha level of 0.05, and no correction for multiple testing was applied to reported values.
Results
Study participants
Data were collected from groups of cocaine-dependent men and women and nondependent healthy control groups of men and women. Baseline demographic and clinical characteristics by cocaine use status and gender are presented in Table 1 . There were no significant differences in race, education, marital status, or smoking status between the cocaine-dependent and control groups. There were significant differences in age and employment status, cocaine-dependent participants were Pre-medication levels taken prior to administration of study drug on the 1st day of cue exposure older and reported greater unemployment levels than controls. Within the cocaine-dependent cohort, there were no differences in treatment status, years of use, or time since last use between men and women. There were no differences between cocaine-dependent and control women in the day of the menstrual cycle at the study visit.
Subjective responses
Yohimbine produced a significant increase in pre-cue anxiety in cocaine-dependent subjects but not in healthy controls (t 212 =4.13, p<0.001; Table 1 ). This finding was consistent for both cocaine-dependent men (t 212 =3.34, p=0.001) and women (t 212 =2.50, p=0.01). In cocaine-dependent subjects, yohimbine increased anxiety, immediately (t 212 = 4.81, p<0.001), 5 min (t 212 =4.66, p<0.001), and 30 min (t 212 = 2.37, p<0.05) after cue exposure (overall f 1, 53 =4.7, p=0.035; Fig. 1a ). There was no effect of yohimbine on post-cue anxiety in control subjects (Fig. 1a) . In cocaine-dependent subjects, a significant gender by treatment interaction was found (f 1, 53 =11.9, p=0.001). Compared with cocaine-dependent men, cocaine-dependent women reported greater anxiety in response to yohimbine immediately (t 212 =2.41, p=0.017) and 5 min (t 212 =2.68, p= 0.008) following cue presentation (Fig. 1b) . Yohimbine produced a trend-level significant increase in pre-cue craving in cocaine-dependent women (t 212 =1.92, p= 0.056) but not in cocaine-dependent men (Table 1) . Exposure to the cue produced a significant increase in craving (t 238 = 6.00, p<0.001; Fig. 2 ). Yohimbine produced a significantly greater craving response as compared with placebo, immediately (t 212 =2.95, p<0.01) and 5 min (t 212 =2.05, p<0.05) following cue presentation. A significant gender by treatment interaction was found (f 1, 53 =8.2, p=0.006). Compared with cocaine-dependent men, cocaine-dependent women reported greater craving in response to yohimbine immediately (t 212 = 2.10, p=0.037) and 5 min (t 212 =2.74, p=0.007) following cue presentation (Fig. 2) .
Endocrine responses
Yohimbine produced a significant increase in salivary cortisol levels (t 95 =14.3, p<0.001) in both cocaine-dependent (t 373 = 7.30, p<0.001) and control (t 373 =4.10, p=0.002) groups (Fig. 3a) . There was no significant effect of cue presentation on salivary cortisol levels in either the cocaine-dependent or control groups, regardless of treatment or gender. Yohimbine produced a significant increase in salivary DHEA levels (t 92 = 3.05, p=0.003) in both the cocaine-dependent (t 751 =2.20, p= 0.028) and control (t 751 =2.11, p=0.036) groups (Fig. 3b) . There was no effect of cue presentation on salivary DHEA levels in either cocaine-dependent or control groups, regardless of treatment or gender. Heart rate responses
There was no effect of yohimbine on pre-cue heart rate (t 875 = 0.83, p=0.407); however, women had higher heart rates than men regardless of treatment (t 875 =4.90, p<0.001; Fig. 4a, b ).
Yohimbine produced a significant increase in post-cue heart rate in all subjects (f 1, 103 =11.7, p<0.001). Yohimbine produced a significantly greater post-cue heart rate response in women as compared with men (f 1, 649 =9.4, p=0.002).
Discussion
In the present study, we investigated the impact of the pharmacological stressor yohimbine on subjective, physiologic, and endocrine responses to a drug-paired cue in cocainedependent men and women and sex-matched control groups. Yohimbine increased salivary cortisol and DHEA levels, and there were no differences between cocaine-dependent subjects and sex-matched control groups in the magnitude of these responses. Yohimbine produced a significant increase in heart rate; however, women had a greater response as compared with men. Yohimbine increased anxiety in cocaine-dependent subjects but not in healthy controls. Consistent with our hypothesis and the preclinical literature, yohimbine appeared to potentiate subjective responses to a cocaine-related cue (Banna et al. 2010; Feltenstein and See 2006) . In addition, cocaine-dependent women reported greater anxiety and craving responses to yohimbine and the cue as compared with cocaine-dependent men (Feltenstein et al. 2011 ). To our knowledge, this is the first study to investigate endocrine, physiologic, and subjective responses a pharmacologic stressor combined with a drug-related cue in cocaine-dependent men and women and to systematically investigate sex differences in these responses. Relative to placebo, cocaine-dependent participants reported significantly higher anxiety following yohimbine administration even before exposure to the cocaine cue. These data are consistent with the findings of McDougle et al. (1994) that yohimbine administration to cocaine-dependent individuals 4162 Psychopharmacology (2014) 231:4157-4165 Fig. 4 Comparison of mean (SE) heart rate following pre-treatment with placebo (PBO) or yohimbine (YOH) between a cocaine-dependent (CD) men and CD women and b healthy control (HC) men and women; pre-, immediately, post-(0), 5, 30, and 60 min after exposure to the cocaine cue during early discontinuation of cocaine use increased nervousness and panic-like symptoms (McDougle et al. 1994) . The anxiogenic effects of yohimbine were not observed in healthy controls, which is consistent with a clinical study that found no effect of yohimbine on subjective responses in healthy controls (Swann et al. 2005 ). To our knowledge, this is the first clinical study to demonstrate significant differences in subjective responses to the provocation of the NA system between cocaine-dependent individuals and healthy controls. Moreover, these findings support the preclinical studies suggesting that chronic cocaine use increases central NA tone and subsequently drives basal levels of anxiety during drug withdrawal (Harris and Aston-Jones 1993; Rudoy and Van Bockstaele 2007) . We also found that yohimbine increased cue-induced anxiety and craving. Clinical studies have found that drug cues elicit anxiety in cocaine-dependent individuals (Fox et al. 2012; Sinha et al. 2003) . The present findings suggest that yohimbine exacerbated the anxiogenic effects of the cue. Stress potentiation of cocaine cue-induced anxiety and craving was greater in cocaine-dependent women as compared with cocaine-dependent men. These data are consistent with the preclinical findings that yohimbine, acting as a pharmacologic stressor, produces greater cue-induced reinstatement of cocaine-seeking behavior in female rodents compared with male rodents, as increased craving in the drug cue exposure paradigm is considered a proxy for an increased propensity to relapse in clinical situations (Feltenstein et al. 2011 ). In addition, there was a trend towards increased pre-cue craving following yohimbine in cocaine-dependent women, but not in men. Female rodents exhibit greater cocaine-seeking behavior in response to a yohimbine challenge than male rodents (Anker and Carroll 2010) . Compared with male rodents, female rodents exhibit greater cross-sensitization to stimulants and stress, thus the present findings of elevated anxiety and craving in cocaine-dependent women but not in men may reflect sex differences in overlap between central stress and reward systems (Camp and Robinson 1988; Holly et al. 2012) . This is particularly important, as stress and drug cues have traditionally been treated as independent factors in the clinical relapse process (Sinha et al. 2000) . Although clinical studies of cocaine-dependent individuals suggest that stress is a significant risk factor for relapse in women (Back et al. 2005; McKay et al. 1996; Waldrop et al. 2009 ), the findings of the present study suggest that the stress-relapse connection is more complex and stress may enhance the salience of cocaine cues for cocaine-dependent women. As such, this study supports the idea that stress followed by drug-related cues could enhance the likelihood of relapse and provides a reasonable human laboratory model to explore sex differences in the stress-cue-relapse connection. Symptoms of cocaine withdrawal including stress-and drug-cue-induced cravings can be attenuated by medications that inhibit NA transmission (Fox et al. 2012; Jobes et al. 2011) . Of note, a recent clinical study found that the alpha-2 agonist guanfacine attenuated craving, anxiety, and negative affect responses to both stress and drug cues in cocaine-dependent women but not in cocaine-dependent men (Fox et al. 2014) . Thus, taken together with the present findings, these data suggest that inhibition of NA transmission may be an effective treatment option for attenuating craving and risk for relapse in cocaine-dependent women.
Following drug-cue exposure, yohimbine-treated subjects (both cocaine-dependent and healthy controls) exhibited significantly higher heart rate, cortisol, and DHEA responses as compared with placebo administration. Noradrenergic transmission to the hypothalamus and hippocampus stimulates the HPA axis (Maccari et al. 1992a, b) . Thus, the increase in adrenal steroid levels found in this study was not surprising. As drug cues also increase NA and HPA axis activities in cocaine-dependent individuals, we expected that cocainedependent subjects would exhibit exacerbated heart rate and adrenal steroid responses to yohimbine and the drug cue (Sinha et al. 2003; Waldrop et al. 2009 ). However, there were no group differences in the magnitude of the physiologic or endocrine responses to the stressor and the drug cue. It is possible that the yohimbine challenge produced a ceiling effect precluding us from observing any additional increase in HPA axis or NA activity. Of note, cocaine-dependent and healthy controls exhibit similar cortisol levels in response to a corticotropin-releasing hormone (CRH) challenge ). Thus, taken with the present findings, it appears that adrenal regulation of steroid levels in response to pharmacological stress remains intact in cocaine-dependent men and women.
Of note, there were no group differences in heart rate responses to yohimbine. In a previous study, heart rate responses to a CRH challenge were significantly higher in cocaine-dependent women than control women ). Thus, we expected that cocaine-dependent women would exhibit a greater heart rate response to yohimbine than control women. Perhaps lower doses of yohimbine would have elucidated differences in the sensitivity of peripheral NA tone between cocaine-dependent and healthy control women. The finding of heightened anxiety and craving response to yohimbine without any effects on either heart rate or HPA hormones suggests dysregulation in central NA tone. The disparity between the biologic and subjective responses to yohimbine is consistent with studies of substance-dependent individuals exposed to laboratory stress tasks (Back et al. 2005; Brady et al. 2009 ). Sinha et al. (2003) proposed that the cardiovascular, endocrine, and subjective responses are semi-independent and represent different components of the stress response. Specifically, subjective responses may represent emotional and behavioral adaptation; whereas, endocrine and heart rate responses represent the biologic adaptation required to maintain homoeostatic balance. Neuroimaging studies may provide additional insight into the role of the NA system in mediating stress and cue reactivity in cocaine dependence.
These findings should be considered in light of some limitations. Subjective ratings and heart rate data were not collected prior to placebo and yohimbine administration, thus the results are based on pre-cue rather than pre-yohimbine assessments and therefore difficult to discern yohimbine effects independent of the cue. We did not control for ovarian hormone status. Elevated progesterone levels have been associated with subjective responses to laboratory stressors and cocaine cues in cocaine-dependent women and attenuates stress-induced potentiation of cue-induced cocaine-seeking behavior in female rodents (Feltenstein et al. 2011; Sinha et al. 2007 ). However, there was no difference between the groups of women in menstrual cycle day and both groups of women completed the study visit during the early luteal phase of the cycle, just prior to the rise in progesterone. Moreover, three of the healthy controls and none of the cocainedependent women reported taking oral contraceptives. Thus, it is unlikely that the present findings were confounded by ovarian hormone levels or oral contraceptives. Duration of abstinence from cocaine may have a significant impact on DHEA levels (Buydens-Branchey et al. 2002) . Thus, variability in the duration of abstinence may have prevented us from detecting group differences among DHEA levels. Finally, as yohimbine has moderate affinity for both serotonin and dopamine receptors and nonspecific effects as a monoamine oxidase inhibitor (MAOI), it is possible that the present findings were not specific to the NA system (Bhattacharya et al. 1991; Millan et al. 2000) . However, the anxiogenic effects of yohimbine were opposite of those that would be expected if yohimbine were acting as an MAOI.
Despite these limitations, this is the first study of stress potentiation of cue reactivity in a clinical population of cocaine-dependent men and women. The present findings are in agreement with the preclinical literature suggesting that stress may increase the craving response to drug cues, and this interaction may be particularly important in cocainedependent women. Importantly, these findings expand a growing literature suggesting important sex/gender differences in risk factors for relapse in cocaine dependence and suggest that medications that attenuate NA activity may be particularly effective treatment strategies for cocainedependent women.
